retatrutide vial (RETA) – Research Peptide Retatrutide: 5-10-20mg*10 vials - Nexus

Consistent with most previous trials, participants with higher pretreatment weight were more likely to lose more weight on GLP-1 RA initiation, with women achieving greater weight reductions than men [14,15,16]

However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower

And keep in mind that while the hype surrounding BPC-157 has been fueled by positive word of mouth, not everyone has had a transformative experience

From the beginning, our mission has been to empower people with chronic conditions to live their best and healthiest lives